Pharmacological Strategies for High-Output Ileostomies in Children: A Narrative Review

Marijke Awouters1, Tim Vanuytsel2, Pauline De Bruyne3

  • 1Department of Paediatrics, University Hospitals Leuven, Leuven, Belgium.

Insights

Pharmacological management for high-output ileostomy (HOI) in children is limited, with little evidence supporting its use. Further research is needed to validate treatment options for paediatric patients with HOI.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Pharmacology
  • Surgical Patient Management

Background:

  • High-output ileostomy (HOI) in pediatric patients often requires pharmacological intervention beyond nutritional management.
  • Limited evidence exists for the pharmacotherapy of HOI in children.

Purpose of the Study:

  • To review the current literature on the pharmacological management of pediatric HOI.
  • To formulate evidence-based recommendations for treating pediatric HOI.

Main Methods:

  • Comprehensive literature search of PubMed and Embase databases.
  • Review of identified articles to formulate clinical recommendations.

Main Results:

  • No dedicated pharmacological studies in pediatric HOI patients were found, except for two case reports on octreotide.
  • Recommendations are extrapolated from adult data and other intestinal failure conditions.
  • Primary recommendations include proton pump inhibitors and loperamide; octreotide for persistent complications; codeine with caution in older children.

Conclusions:

  • Pharmacological treatment options for pediatric HOI are scarce, with a significant lack of supporting evidence.
  • There is a critical need for dedicated research to validate pharmacotherapy in this vulnerable patient population.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
115
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
131
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
174
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
70
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
109
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
160